Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
|
CelLynx Group, Inc. (CYNX)
|
Add to portfolio |
|
|
|
| Price: |
$0.00
| | Metrics |
| OS: |
2.05
|
B
| |
|
|
| Market cap: |
$204.8
|
k
| |
|
|
|
Net debt:
|
$2.89
|
M
| |
3.7
|
x Debt/EBITDA
|
|
EV:
|
$3.09
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$773.7
|
k
| |
4.0
|
x EV/EBITDA
|
|
EBIT
|
$774.7
|
k
| |
4.0
|
x EV/EBIT
|
| EPS |
$0.00
| |
0.0
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Sep-30-12 | Sep-30-11 | Sep-30-10 | Sep-30-09 | Sep-30-08 | Jun-30-08 | Jun-30-07 |
| Revenues | 2.1 | 1.8 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | 14.9% | 1942.2% | | | | -45.9% | |
| Cost of goods sold | 0.6 | 1.6 | 4.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 1.5 | 0.2 | -4.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 70.4% | 13.0% | -4452.4% | | | 100.0% | 111.5% |
| Selling, general and administrative | | | | 0.0 | | 0.0 | 0.0 |
| Research and development | 0.0 | | 0.1 | | 308.9 | | |
| General and administrative | 0.6 | 1.6 | 4.0 | 0.0 | 4,397.1 | 0.0 | 0.0 |
| EBIT | 0.9 | -1.4 | -4.0 | 0.0 | -4,706.0 | 0.0 | 0.0 |
| EBIT margin | 40.8% | -73.9% | -4452.4% | | | 100.0% | 100.0% |
| Pre-tax income | -0.6 | -1.3 | -3.6 | -4.0 | -6,658.5 | -1.0 | -0.1 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -0.6 | -1.3 | -3.6 | -4.0 | -6,658.5 | -1.0 | -0.1 |
| Net margin | -26.9% | -71.8% | -4047.5% | | | -4627.6% | -263.6% |
| |
| Diluted EPS | $0.00 | ($0.01) | ($0.02) | $0.00 | ($0.16) | ($0.03) | $0.00 |
| Shares outstanding (diluted) | 710.5 | 185.2 | 161.0 | 125,095.0 | 40,407.5 | 37.6 | 36.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|